Cutibacterium acnes (C. acnes) can become an exacerbating factor in acne vulgaris. Clindamycin has been most frequently used for the treatment of inflammatory acne vulgaris. We studied clindamycin susceptibility and resistance determinants of C. acnes isolated from acne patients in Japan. The isolation rate of clindamycin-resistant C. acnes had significantly increased from 20.3 % in 2009-2010 to 44.1 % in 2016-2017. Strains carrying erm(X), which confers high-level resistance to clindamycin, had significantly increased from 1.4 to 11.8 %. Sequence analysis of the resistance determinant showed that erm(X) was coded on transposon Tn5432. A transconjugation experiment showed that erm(X) can be transferred between C. acnes strains with high frequency and the transconjugants harboured transposon Tn5432 encoding erm(X). Our data show the transconjugation of erm(X) in C. acnes and strongly suggest that the transmission of erm(X) between C. acnes contributes to the increase and spread of clindamycin-resistant C. acnes strains in acne patients.
INTRODUCTION
Cutibacterium (formerly Propionibacterium) acnes, a skin inhabitant, causes inflammation by overgrowth in closed follicles [1] . Therefore, C. acnes is cited as an exacerbating factor in acne vulgaris. Antibiotics are used for the eradication of C. acnes in the treatment of acne vulgaris. Notably, topical clindamycin is recommended by acne treatment guidelines in several countries [2] [3] [4] . However, antimicrobial-resistant C. acnes strains have been isolated from acne patients; in particular, clindamycin-resistant strains are spreading rapidly worldwide [5] [6] [7] . Although clindamycin has a different chemical structure to macrolide antibiotics, it similarly acts on 23S rRNA, a subunit of the 50S ribosome, inhibiting protein synthesis. Mutation and modification of 23S rRNA confers resistance to both macrolides and clindamycin in C. acnes by decreasing drug affinity [8] . The mutations of the 23S rRNA gene that promote resistance are reportedly a change of guanine to adenine at position 2057 (A2057G), adenine to guanine at positions 2058 and 2059 (A2058G, A2059G), and cytosine to guanine at position 2611 (C2611G) [6, 9] . The mutations result in high-level resistance to macrolides but moderate or low resistance to clindamycin [6] . Modification of 23S rRNA occurs by the acquisition of erm(X), which codes for rRNA methyltransferase. Methylation of 23S rRNA by the erm(X) product causes high-level resistance to both macrolides and clindamycin [6, 8] . So far, 35 homologues and variants are recognized in the erm family [10] . Staphylococci, which are gram-positive skin bacteria, are reported to carry ermA, ermB and ermC [11, 12] . C. acnes that carry only erm(X) have been reported [13] . erm(X) is also detected in bifidobacteria and Actinobacillus schaalii [14, 15] , and is located on a transposon, Tn5432, which originates from the chromosome of Corynebacterium [7] . This transposon consists of the erm(X) gene flanked both sides by an insertion sequence, IS1249 [7, 16] . However, C. acnes carrying erm(X) has been seen as less important in clinical settings because it was thought to be responsible for resistance in fewer than 10 % of resistant strains [6] . Therefore, the transmission of erm(X) between C. acnes strains has not been demonstrated.
Recently, we showed a significant increase in clindamycinresistant C. acnes strains isolated from acne patients in Japan [17] . In this study, we present the latest data on the prevalence of clindamycin-resistant C. acnes carrying erm(X) and demonstrate the transconjugation of erm(X) between different isolates of C. acnes.
METHODS
Bacterial strains and growth conditions Thirty-four C. acnes strains were collected from acne patients that visited the Toranomon Hospital in Japan between 2016 and 2017. Culture of C. acnes was conducted according to previous methods [11] .
For the transconjugation experiments, C. acnes strain T-50c (clinical isolate; phylogenetic type: IA1; SLST: A2) was used as a donor. This strain harbours Tn5432 containing erm(X) and is 99.9 % identical to Tn5432 in C. acnes (GenBank accession number AF411029). To select transconjugants, C. acnes ATCC6919 (type strain; phylogenetic type: IA1; SLST: A1), T-141a (clinical isolate; phylogenetic type: IA2; SLST: F4), ATCC11828 (antimicrobial susceptible strain; phylogenetic type: II; SLST: K9), which were conferred rifampicin resistance by chromosomal mutation were used as recipients. In addition, to evaluate the re-conjugation ability of transconjugants, C. acnes ATCC11828, which was conferred quinolone resistance by chromosomal mutation, was used as a recipient for the re-transconjugation experiment.
Susceptibility testing
Antimicrobial susceptibility was evaluated by the determination of minimum inhibitory concentration (MIC) using the agar dilution method with Brucella agar (Becton Dickinson, NJ, USA) containing 5 % lysed defibrinated sheep blood (Nippon Bio-Test Laboratories, Tokyo, Japan) [18, 19] . The antimicrobial agents, clarithromycin and clindamycin hydrochloride, were purchased from Tokyo Chemical Industries (Tokyo, Japan). The breakpoint of clindamycin for C. acnes was defined using the MIC values for the quality control strains and the Clinical and Laboratory Standards Institute (CLSI) criteria (!8 µg ml
À1
) [20] . The breakpoint of clarithromycin was defined by our laboratory (!2 µg ml À1 ) [11] .
Identification of clindamycin-resistance determinants and typing of transconjugants
The detection of erm(X) and the identification of the 23S rRNA mutations were carried out by PCR and DNA sequencing, respectively, using methods described previously [17] . Transposon Tn5432 containing erm(X) and IS1249, was identified according to the methods of ElMahdy et al. [7] .
The transconjugants were matched to the recipients used by phylogenetic typing and single-locus sequence typing (SLST) [1, 13] .
Filter mating method C. acnes strains were grown for 3 days in modified GAM Broth (Nissui Pharmaceutical, Tokyo, Japan) at 35 C in anaerobic conditions. After incubation, 50 µl of bacterial culture was inoculated in 20 ml of fresh broth, and the culture was incubated until OD 600 =0.2. Subsequently, each bacterial suspension of donor and recipient strains was mixed in a 4 : 1 bacterial population ratio and the culture was filtered through nitrocellulose membranes (diameter, 13 mm; pore size, 0.45 µm; ADVANTEC, Tokyo, Japan). Each membrane was applied to modified GAM Agar (Nissui Pharmaceutical) and was incubated for 5 days at 35 C in anaerobic conditions. Bacteria on the membranes were transferred to the broth and suspended. The bacterial suspension was spread on agar plates containing 50 µg ml À1 of rifampicin (Wako Pure Chemical Industries) and 5 µg ml À1 of clarithromycin. After incubation in anaerobic conditions, the growing colonies were selected as transconjugants. Additionally, to evaluate whether transconjugants had the ability of transmission, the re-transconjugant experiment was performed using the filter mating method. Re-transconjugants were selected on plates containing 5 µg ml À1 of levofloxacin (Tokyo Chemical Industries) and clarithromycin. The conjugation frequency was calculated as the mean±SD from three independent tests.
RESULTS
Antimicrobial-resistance and clindamycinresistance determinants in C. acnes isolated from acne patients Of the 34 C. acnes strains isolated from acne patients in 2016-2017, the total resistance rate of clindamycin (44.1 %, 15/34) was significantly higher than that recorded in 2009-2010 (20.3 %, P<0.05) [11] . Strains with a 23S rRNA mutation accounted for 32.4 % (11/34) of all strains ( Table 1) . The proportion of strains carrying erm(X) (11.8 %) was significantly higher than previously reported in Japan (1.4 %, P<0.05) [11] . In addition, we isolated five (14.7 %) highly clindamycin-resistant strains that did not have a mutation in 23S rRNA or harbour the erm(X) gene (Table 1 , indicated 'Unknown').
Transconjugation of erm(X) between C. acnes strains erm(X) in C. acnes is conserved on the transposon Tn5432, which encodes the transposable element IS1249 flanking both sides of erm(X) [6] . When Tn5432 was detected in 11 C. acnes carrying erm(X) isolated in 2009-2017, Tn5432 was detected in seven (63.6 %) of these. Therefore, it was considered that Tn5432 is strongly related to the acquisition of the erm(X). The transconjugation experiment of erm(X) between C. acnes was performed using the filter mating method. erm(X) was transferred from the donor T-50c, to ATCC6919-REP at a high frequency, 1.6Â10 À4 ± 0.7Â10
À4
( Table 2) . erm(X) was transferred from the T-50c donor to T-141a-REP and ATCC11828-REP at a frequency of 2.1Â10 À3 ± 0.2Â10 À3 and 2.9Â10 À4 ± 0.8Â10
, respectively. The frequency of erm(X) transfer to T-141a-REP was ten times higher than that of other strains. Furthermore, when a re-transconjugation experiment of erm(X) was performed using the transconjugant of T-141a-REP (Table 2 , indicated 'T-141a transconjugant') as a donor to ATCC11828-QL, erm(X) was transferred at a frequency of 2.7Â10 À4 ± 0.5Â10
. Re-transconjugation frequency was the same as that from T-50c to ATCC11828-REP.
To confirm whether the transconjugants were identical to the recipients, we determined the phylogenetic type and SLST in C. acnes. All transconjugants were classified into the same phylogenetic type and SLST type as the recipient. Additionally, all transconjugants showed high-level resistance to clarithromycin and clindamycin, like the erm(X) donor strain (Table 2) . Furthermore, all transconjugants had Tn5432 containing erm(X) and the sequences of Tn5432 were completely consistent with that of the donor strain. These results demonstrated that erm(X) is transferred between strains of C. acnes via Tn5432.
DISCUSSION
C. acnes carrying erm(X) composes approximately 10 % of macrolide-resistant strains isolated from acne patients in Europe [21] . In Japan between 2009-2010, erm(X) was detected at the same prevalence as in Europe, being present in 1.4 % of all strains and 6.3 % of resistant strains [11] . However, in Japan between 2013-2015, the isolation rate of erm(X) greatly increased to 8.6 % of all strains and 19.4 % of resistant strains [17] . Likewise, in 2016-2017, there was a high erm(X) detection rate of 11.8 % in all strains and in 20.0 % of resistant strains. It is suggested that the increase of C. acnes carrying erm(X) contributes to an increased proportion of clindamycin-resistant C. acne in Japan.
Transposon Tn5432 containing erm(X) in C. acnes is suggested to originate from corynebacterium because erm(X) was first found on the chromosome of Corynebacterium striatum M82B [7, 16] . It is reported that erm(X), flanked either side by IS3 and IS1249, in bifidobacteria, was transferred to Enterococcus faecalis at low-frequency by the filter mating method [14] . Detection of erm(X) and the flanking mobile elements in C. acnes revealed that Tn5432 was found in many C. acnes carrying erm(X). Thus, we inferred that erm(X) transfers to other strains via Tn5432. We performed the transconjugation experiment of erm(X) by the filter mating method. The results revealed that erm(X) is able to transfer between C. acnes at high frequency. Additionally, our data strongly suggest that Tn5432 containing erm(X) transfers as a conjugative transposon.
C. acnes carrying erm(X) from acne patients is isolated at a low rate, although erm(X) transferred with high frequency in vitro [6] . Strains with and without erm(X) were mated at high density by the filter mating method. The bacterial population of C. acnes on human skin is considerably lower than in vitro cultures, and many other bacterial species inhabit the skin, including staphylococci and corynebacterium [22] . Furthermore, we have previously reported that transmission of C. acnes strains between acne patients could not be detected [11] . We considered that C. acnes strains rarely mate on the skin. This study has revealed that the incidence of C. acnes carrying erm(X) has increased, so it is expected that mating opportunities on human skin will also increase. Therefore, the prevalence of C. acnes carrying erm(X) may gradually increase in the future.
The conjugation frequency of erm(X) was different between recipient strains. The CRISPR/Cas system is known as a control mechanism for the acquisition of foreign genes [23] . C. acnes strains belonging to phylogenetic type II harbour the CRISPR/Cas gene, which is associated with the acquisition of linear plasmids [23] . In this study, there was no difference in the frequency of acquisition of erm(X) between ATCC11828 classified type II and ATCC6919 classified type IA1, which do not harbour the CRISPR/Cas gene. Hence, the relationship between the acquisition of erm(X) and CRISPR/Cas system was not observed. Additionally, the clinical isolate T-141a, which was classified into type IA2 (SLST: F), exhibited a higher conjugation frequency than other strains. Strains belonging to clade F were dominant in acne patients in Japan [17] . Although the strains belonging to clade F comprised 13.0 % (9/69) of all strains in 2009-2010, their frequency was significantly increased in 2016-2017, with 38.2 % (13/34) belonging to clade F (P<0.05, data not shown). However, the relationship between the strains belonging to clade F and acne pathogenicity is unknown. We suspect that the increased prevalence of strains belonging to clade F in acne patients promotes the increase of C. acnes carrying erm(X).
Topical clindamycin is recommended by acne treatment guidelines in the USA, Europe and Japan [2] [3] [4] . It is expected that when topical clindamycin is applied, that the drug concentration in follicles will be high, at 600 µg cm
À2
, because the drug is directly applied [24] . However, the acquisition of erm(X) confers high-level resistance to clindamycin (MIC !512 µg ml À1 ) in C. acnes [6] . Therefore, the increase in C. acnes carrying erm(X) could become a severe problem because they could decrease the efficacy of topical clindamycin for the treatment of acne vulgaris.
In this study, we revealed that the proportion of C. acnes carrying erm(X) has significantly increased in Japan. Furthermore, we demonstrate the transmission of erm(X) by Tn5432 between C. acnes strains in vitro. Our results strongly suggest that the spread of erm(X) in C. acnes contributes to the increase in clindamycin-resistant strains isolated from acne patients.
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